283 related articles for article (PubMed ID: 31171012)
1. β-Catenin nuclear localization positively feeds back on EGF/EGFR-attenuated AJAP1 expression in breast cancer.
Xu C; Liu F; Xiang G; Cao L; Wang S; Liu J; Meng Q; Xu D; Lv S; Jiao J; Niu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):238. PubMed ID: 31171012
[TBL] [Abstract][Full Text] [Related]
2. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
Shen H; Yan W; Yuan J; Wang Z; Wang C
J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
[TBL] [Abstract][Full Text] [Related]
3. Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.
Li X; Liang W; Liu J; Lin C; Wu S; Song L; Yuan Z
Breast Cancer Res; 2014 Oct; 16(5):465. PubMed ID: 25341494
[TBL] [Abstract][Full Text] [Related]
4. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway.
Li Q; Ye L; Guo W; Wang M; Huang S; Peng X
J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312
[TBL] [Abstract][Full Text] [Related]
5. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
6. Silencing of
Jiang L; Liu Y; Pan Y; Tan Z; Wang J; Zheng G; Qian C; Xu S; Zhu X; Ma W; Guerrini S; Infante-Cossio P; Wu J; Ge M; Cai X
Gland Surg; 2023 Jun; 12(6):834-852. PubMed ID: 37441023
[TBL] [Abstract][Full Text] [Related]
7. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
[TBL] [Abstract][Full Text] [Related]
8. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
[TBL] [Abstract][Full Text] [Related]
9. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.
Gao S; Ge A; Xu S; You Z; Ning S; Zhao Y; Pang D
J Exp Clin Cancer Res; 2017 Dec; 36(1):179. PubMed ID: 29216929
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.
Lee CH; Hung HW; Hung PH; Shieh YS
Mol Cancer; 2010 Mar; 9():64. PubMed ID: 20302655
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation.
Luo X; Xiong X; Shao Q; Xiang T; Li L; Yin X; Li X; Tao Q; Ren G
Oncotarget; 2017 Jul; 8(30):48875-48888. PubMed ID: 28388578
[TBL] [Abstract][Full Text] [Related]
13. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
14. Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation.
Li W; Hou JZ; Niu J; Xi ZQ; Ma C; Sun H; Wang CJ; Fang D; Li Q; Xie SQ
Cell Commun Signal; 2018 Nov; 16(1):82. PubMed ID: 30445978
[TBL] [Abstract][Full Text] [Related]
15. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
16. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
[TBL] [Abstract][Full Text] [Related]
17. A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.
Hsieh TH; Hsu CY; Tsai CF; Chiu CC; Liang SS; Wang TN; Kuo PL; Long CY; Tsai EM
Sci Rep; 2016 Jan; 6():19156. PubMed ID: 26750754
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
19. Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex.
Li Y; Jin L; Ye F; Ma Q; Yang Z; Liu D; Yang J; Ma D; Gao Q
Oncotarget; 2017 May; 8(18):30344-30356. PubMed ID: 28427223
[TBL] [Abstract][Full Text] [Related]
20. Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
Wang J; Barnes RO; West NR; Olson M; Chu JE; Watson PH
Breast Cancer Res; 2008; 10(3):R51. PubMed ID: 18534028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]